Miami, FL – September 2024 –The International Society for Stem Cell Application (ISSCA), a division of Global Stem Cells Group (GSCG), is pleased to announce the launch of its new training series, Mastering Next-Generation Cellular Therapies and Regenerative Medicine 2.0. This training will be held in two prominent locations: Cancun, Mexico, on October 4th and 5th, 2024, followed by Dubai, UAE, on November 22nd and 23rd, 2024.
Building on ISSCA’s long-standing commitment to advancing regenerative medicine, this training series aims to provide participants with the most up-to-date knowledge and techniques in the field. This 2.0 iteration of ISSCA’s training is designed to focus on the next generation of cellular therapies, with the goal of equipping healthcare professionals with the tools necessary to explore and incorporate these innovations into their practices. The agenda for this training is structured to present the most recent advancements, offering attendees both theoretical knowledge and practical experience in cutting-edge therapies.
Key Topics to be Covered:
- NK Cells for Anti-Aging and Immune Support: This session is expected to provide insights into the emerging applications of NK cells in enhancing immune responses and supporting anti-aging treatments.
- Progenicell and Nanorevive Technologies: These innovative technologies will be introduced, highlighting their potential roles in tissue repair and cellular recovery.
- Peptides for Longevity and Tissue Healing: Participants will explore the latest applications of peptides, which may contribute to improved tissue regeneration, reduced inflammation, and overall health optimization.
- Wharton’s Jelly in Regenerative Medicine: Attendees will learn about the promising uses of Wharton’s Jelly in regenerative medicine, particularly in addressing degenerative conditions.
- Biohacking for Medical Optimization: This session will delve into biohacking principles and their potential integration into modern clinical practices for enhanced patient outcomes.
The Importance of Staying at the Forefront of Cellular Therapies
In light of the rapidly evolving landscape of regenerative medicine, it is increasingly important for medical professionals to remain at the forefront of technological advancements. This training seeks to support clinicians in staying updated with the latest developments in the field, which may have a significant impact on improving patient outcomes. By mastering next-generation therapies such as NK cells, peptides, and Wharton’s Jelly applications, we believe attendees will be better positioned to explore innovative treatment options in their clinical practices.
ISSCA’s Mission and Impact
ISSCA is dedicated to advancing the science and application of cellular therapies and regenerative medicine. The organization continuously strives to bring the most current developments to healthcare professionals, thereby fostering the adoption of advanced techniques that may improve patient care. Through ongoing research, ISSCA endeavors to develop new tools, methodologies, and educational resources that will empower doctors to enhance their medical practices.
The impact of ISSCA’s work extends across the global medical community, offering practitioners access to the most up-to-date therapies and enabling them to stay ahead of the curve in this rapidly changing field. By facilitating this comprehensive training, ISSCA aims to contribute to the ongoing professional development of doctors and researchers, ensuring that they are equipped with the latest knowledge and techniques in regenerative medicine.
Event Highlights:
- Comprehensive coverage of topics including NK Cells, Peptides, Progenicell, and other emerging therapies;
- Hands-on training sessions, designed to offer practical experience in next-generation regenerative treatments;
- Two international training opportunities: Cancun, Mexico, and Dubai, UAE;
- ISSCA’s latest research-driven content, developed to support practitioners in staying informed of the latest advancements in the field;
- Certification upon completion, recognizing expertise in cellular therapies and regenerative medicine; and
- Networking opportunities with global leaders and experts in the field.
Event Details:
- Cancun, Mexico: October 4 & 5, 2024
- Dubai, UAE: November 22 & 23, 2024
- Contact: For further information and registration, please visit www.issca.com or contact info@stemcellsgroup.com | +1 (754) 799 4946
ISSCA anticipates that these training events will provide a valuable opportunity for healthcare professionals, clinicians, and researchers to gain essential insights into the future of regenerative medicine. Early registration is encouraged due to limited capacity.
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a leading organization in the field of regenerative medicine. It is dedicated to advancing the science and practice of stem cell therapy and regenerative medicine through education, certification, research, and training. ISSCA provides certification training in cities worldwide, recognizing the importance of standards and certifications in regenerative medicine as a medical specialty.
ISSCA’s mission is to promote the benefits of stem cell medicine to patients globally, ensure the quality and uniformity of regenerative medicine practices, and establish itself as a global leader in the certification and education of medical professionals in this field. The organization is a distinguished division of the Global Stem Cells Group (GSCG) and has over 15 years of experience in the industry, making significant contributions to the advancement and dissemination of regenerative medicine knowledge and practices.
About Global Stem Cells Group
Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
